Trial intelligence / Profile preview

Folic Acid for Renal Endothelial Function in Diabetic Nephropathy

NCT00136188Phase 3Completed

Sponsor
FAU Erlangen-Nürnberg Medical Faculty
Start
Aug 2009
Primary completion
Dec 2011
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of folic acid in diabetic nephropathy (DN), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started Aug 2009; status: completed.

02

Drugs

folic acid
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT00136188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00136188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call